FDA Approves Less Frequent Lebrikizumab Dosing

• by Kathryn Wighton

• June 10, 2026

Characteristics of Dupilumab-Treated Patients with Atopic Dermatitis Over Time: A Cross-Sectional Assessment of Potential Channeling Bias upon Pediatric Label Extension

• by Julie Barberio, Venkatesh Harikrishnan, Shiyao Gao, Andrea Marcus, Sarah-Jo Sinnott

• July 18, 2026

Medical Oddities: Can a Home Be Preventive Care?

This week’s medical plot twists involved ants, architecture, and auditory hallucinations.

• by Teraya Smith

• May 28, 2026

• 6 min

FDA monthly preview: Key September decisions to watch

Several FDA decisions across multiple specialties are expected this month.

• by Kathryn Wighton

• August 28, 2026

• 5 min